Europe Intrauterine Contraceptive Devices Market Size, Share & Growth

Share on

Europe Intrauterine Contraceptive Devices Market Analysis Report – Segmented By Product Type and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, and Rest of Europe) – Industry Size, Share, Trends, and Growth Forecast (2021 to 2026)

Pulished: April, 2021

ID: 1031

Pages: 136

Europe Intrauterine Contraceptive Devices Market Size (2021 to 2026)

The size of the Europe Intrauterine Contraceptive Devices (IUD’S) Market was worth USD 371.20 million in 2021. This figure is estimated to reach USD 473.75 million by the end of 2026, with a growing potential of 5.00% during the forecast period.

Technological advancements, growing demand and usage of contraceptive devices, and new product launches by the market participants are majorly driving the market growth. The latest and advanced intrauterine devices that provide a low risk of ectopic pregnancy are positive signs of market growth. The number of hospital visits with gynecological disorders for women is significantly increasing in Europe, which is further expected to add fuel to the market growth.

Side-effects associated with these devices are expected to restrain the market growth to a small extent. Lack of awareness among the people in the usage of these devices and the high cost of the tools are significant challenges.

This research report has been segmented and sub-segmented the Europe Intrauterine Contraceptive Devices Market into the following categories:

By Product: Hormonal and Copper Luds
By End User: Hospitals, Gynecology Clinics, Community Healthcare and Others
By Country: United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, and Rest of Europe

Regional Analysis:

Europe is the second-largest region, followed by North America in leading the global ICD market due to the technological advancements and increased usage of these devices.

Germany is expected to lead the European intrauterine contraceptive devices market between 2020 and 2025. In Germany, the government had taken many initiatives and processed some proposals in the recent past with the other organizations, which is significantly increased the market growth.

Following Germany, the UK market is expected to stand 2nd in accounting for the leading shares in the European market during the forecast period. The introduction of new drugs, medical devices, growth in the number of people opting to avoid pregnancy, and various government initiatives to support the United Kingdom market. The utilization of these devices in the United Kingdom is higher than the entire usage of the European region.

The Italian market is expected to look like a lucrative region for these devices due to the high number of unplanned pregnancies and the complications relevant to them, and the increasing incidence rate of sexually transmitted diseases.

Some of the promising companies operating in the Europe Intrauterine Contraceptive Devices Market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals Inc., Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamoto Industries, Inc., and Pfizer.

1.Introduction

1.1 Market Definition

1.2 Study Deliverables

1.3 Base Currency, Base Year and Forecast Periods

1.4 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Research Phases

2.2.1 Secondary Research

2.2.2 Primary Research

2.2.3 Econometric Modelling

2.2.4 Expert Validation

2.3 Analysis Design

2.4 Study Timeline

3. Overview

3.1 Executive Summary

3.2 Key Inferences

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

4.1 Market Drivers

4.2 Market Restraints

4.3 Key Challenges

4.4 Current Opportunities in the Market

5. Market Segmentation

5.1 By Product Type

5.1.1 Hormonal Intrauterine Devices

5.1.2 Copper Intrauterine Devices

6. Geographical Analysis

6.1 Introduction

6.2 U.K

6.3 Spain

6.4 Germany

6.5 Italy

6.6 France

7.Strategic Analysis

7.1 PESTLE analysis

7.1.1 Political

7.1.2 Economic

7.1.3 Social

7.1.4 Technological

7.1.5 Legal

7.1.6 Environmental

7.2 Porter’s Five analysis

7.2.1 Bargaining Power of Suppliers

7.2.2 Bargaining Power of Consumers

7.2.3 Threat of New Entrants

7.2.4 Threat of Substitute Products and Services

7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis

8.1 Agile Therapeutics

8.1.1 Overview

8.1.2 Product Analysis

8.1.3 Financial analysis

8.1.4 Recent Developments

8.1.5 SWOT analysis

8.1.6 Analyst View

8.2 Actavis PLC

8.3 ANI Pharmaceuticals

8.4 Bayer

8.5 Teva Pharmaceutical

8.6 Besins HealthCare

8.7 Brecuro Medical

8.8 Effik International

8.9 Eurogine

8.10 HLL Lifecare

8.11 HRA Pharma

8.12 Lupin Pharmaceuticals

8.13 Okamato Industries

8.14 Pfizer

9.Competitive Landscape

9.1 Market share analysis

9.2 Merger and Acquisition Analysis

9.3 Agreements, collaborations and Joint Ventures

9.4 New Product Launches

10. Market outlook and Investment oppurtunities

Appendix

a) List of Tables

b) List of Figures

Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Europe intrauterine Devices Market, By Product Type, From 2021 to 2026 (USD Million)
Europe Hormonal Intrauterine Devices Market, By Region, From 2021 to 2026 (USD Million)
Europe Copper intrauterine Devices Market, By Region, From 2021 to 2026 (USD Million)
U.K. intrauterine Devices Market, By Product Type, From 2021 to 2026 (USD Million)
Germany intrauterine Devices Market, By Product Type, From 2021 to 2026 (USD Million)
France intrauterine Devices Market, By Product Type, From 2021 to 2026 (USD Million)
Italy intrauterine Devices Market, By Product Type, From 2021 to 2026 (USD Million)
Spain intrauterine Devices Market, By Product Type, From 2021 to 2026 (USD Million)